Filtered By:
Vaccination: Meningitis Vaccine
Countries: China Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 34 results found since Jan 2013.
Effectiveness of 13-valent pneumococcal conjugate vaccine on all-cause pneumonia in children under 5 years in Shanghai, China: An observational study
CONCLUSIONS: PCV13 vaccination among children aged 0-5 years substantially reduced the incidence of all-cause pneumonia. Direct immunization of children under 5 years is an effective strategy to combat outpatient pneumonia, and hospitalized pneumonia.PMID:37620204 | DOI:10.1016/j.vaccine.2023.08.041
Source: Vaccine - August 24, 2023 Category: Allergy & Immunology Authors: Jie Tian Bo Zheng Laibao Yang Ying Guan Chunze Xu Weibing Wang Source Type: research
Influenza and pneumococcal vaccination coverage and associated factors in patients hospitalized with acute exacerbations of COPD in China: Findings from the real-world data
CONCLUSIONS: Influenza and pneumococcal vaccination coverage are extremely low. Urgent measures are necessary to increase vaccination coverage among inpatients with AECOPD in China.PMID:37488669 | DOI:10.1097/CM9.0000000000002790
Source: Chinese Medical Journal - July 24, 2023 Category: General Medicine Authors: Ruoxi He Xiaoxia Ren Ke Huang Jieping Lei Hongtao Niu Wei Li Fen Dong Baicun Li Ye Wang Ting Yang Chen Wang Source Type: research
Cost-effectiveness of pneumococcal vaccines among adults aged 65 years and older in China: A comparative study
Vaccine. 2022 Dec 13:S0264-410X(22)01515-8. doi: 10.1016/j.vaccine.2022.12.004. Online ahead of print.NO ABSTRACTPMID:36522264 | DOI:10.1016/j.vaccine.2022.12.004
Source: Vaccine - December 15, 2022 Category: Allergy & Immunology Authors: Jia Guo Haijun Zhang Haonan Zhang Xiaozhen Lai Jiahao Wang Huangyufei Feng Hai Fang Source Type: research
A phase II, single-center, randomized, double-blind, parallel control clinical study evaluating the immunogenicity and safety of a two-dose schedule of serogroups ACYW meningococcal polysaccharide conjugate vaccine
CONCLUSION: The serogroups ACYW meningococcal polysaccharide conjugate vaccine was safe and effective in the population aged 3-35 months. The vaccine efficacy and safety of the 20-μg dose group were not less than that of the 40-μg dose group.PMID:36243590 | DOI:10.1016/j.vaccine.2022.08.001
Source: Vaccine - October 15, 2022 Category: Allergy & Immunology Authors: Yi Mo Yanan Li Gang Liu Junji Chen Dingkai Wei Jigang Wu Qiuyan Meng Zhi Li Zhaojun Mo Source Type: research
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial
CONCLUSIONS: The coadministration of the inactivated SARS-CoV-2 vaccine and IIV4/PPV23 is safe with satisfactory immunogenicity. This study is registered with ClinicalTrials.gov, NCT04790851.PMID:35931636 | DOI:10.1016/j.vaccine.2022.07.033
Source: Vaccine - August 5, 2022 Category: Allergy & Immunology Authors: Haiping Chen Zhuoying Huang Shaoying Chang Mei Hu Qingbin Lu Yuntao Zhang Hui Wang Yanhui Xiao Hui Wang Yonghong Ge Yong Zou Fuqiang Cui Shasha Han Min Zhang Shengyi Wang Xiaoping Zhu Biao Zhang Zhi Li Jia Ren Xiao Chen Rui Ma Lei Zhang Xue Guo Linyun Luo Source Type: research
Immunogenicity of meningococcal polysaccharide conjugate vaccine as a replacement for meningococcal polysaccharide vaccine in children in Guangzhou, China
Vaccine. 2022 Jan 27:S0264-410X(21)01200-7. doi: 10.1016/j.vaccine.2021.09.021. Online ahead of print.ABSTRACTTo assess the durability of antibody persistence after substitution of the MPCV vaccine for the MPSV-A vaccine in children, an observational study was conducted in children who voluntarily received two doses of MPCV-AC instead of MPSV-A between March 2017 and March 2018 in Guangzhou, China. In total, 131 and 47 participants were enrolled in the 3-year-old and 6-year-old groups, respectively. In the 3-year-old group, the seroprotection rate and GMT values for Men A and Men C were raised significantly after 1-month p...
Source: Vaccine - January 31, 2022 Category: Allergy & Immunology Authors: Qing He Jiali Xiao Meizhen Liu Zhencui Li Jiangxiong Xu Zhoubin Zhang Source Type: research
Etiological and epidemiological features of acute meningitis or encephalitis in China: a nationwide active surveillance study
Lancet Reg Health West Pac. 2022 Jan 3;20:100361. doi: 10.1016/j.lanwpc.2021.100361. eCollection 2022 Mar.ABSTRACTBACKGROUND: Acute meningitis or encephalitis (AME) results from a neurological infection causing high case fatality and severe sequelae. AME lacked comprehensive surveillance in China.METHODS: Nation-wide surveillance of all-age patients with AME syndromes was conducted in 144 sentinel hospitals of 29 provinces in China. Eleven AME-causative viral and bacterial pathogens were tested with multiple diagnostic methods.FINDINGS: Between 2009 and 2018, 20,454 AME patients were recruited for tests. Based on 9,079 pat...
Source: Herpes - January 17, 2022 Category: Infectious Diseases Authors: Li-Ping Wang Yang Yuan Ying-Le Liu Qing-Bin Lu Lu-Sha Shi Xiang Ren Shi-Xia Zhou Hai-Yang Zhang Xiao-Ai Zhang Xin Wang Yi-Fei Wang Sheng-Hong Lin Cui-Hong Zhang Meng-Jie Geng Jun Li Shi-Wen Zhao Zhi-Gang Yi Xiao Chen Zuo-Sen Yang Lei Meng Xin-Hua Wang Ai- Source Type: research
Evaluation of effectiveness, safety and cost-benefit of the 23- valent pneumococcal capsular polysaccharide vaccine for HIV-Infected patients
CONCLUSION: Our study results showed that PPV23 can be safely and effectively administered to HIV-1 infected individuals and effectively preventing Streptococcal pneumonia. Considering the cost-benefit of vaccination among HIV-infected persons, as it has been reported in our study, it is necessary to promote the widespread use of the vaccine among HIV-infected persons in the future.PMID:34857419 | DOI:10.1016/j.vaccine.2021.11.058
Source: Vaccine - December 3, 2021 Category: Allergy & Immunology Authors: Xiaobai Zou Jianmei He Jun Zheng Mengran Liang Jinjin Gao Jianwen Huang Yang Jiang Yonglin Jiang Xi Chen Source Type: research
